NCT00052364View on ClinicalTrials.gov

Oxaliplatin in Treating Patients With Liver Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

January 31, 2006

Conditions
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver CancerRecurrent Adult Primary Liver Cancer
Interventions
DRUG

oxaliplatin

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

91010

City of Hope, Duarte

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00052364 - Oxaliplatin in Treating Patients With Liver Cancer | Biotech Hunter | Biotech Hunter